Shuji Kanmura

机构：Kagoshima University, Kagoshima University Hospital · ORCID：0000-0002-6625-4180

发表论文 198 篇 · 总被引 1580 次 · h-index 21

代表论文

• Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study (2024 · The Lancet · 被引 114)
• Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study (2024 · Journal of Gastroenterology · 被引 12)
• First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study (2025 · Journal of Gastroenterology · 被引 7)
• Effect of sprayable, highly adhesive hydrophobized gelatin microparticles on esophageal stenosis after endoscopic submucosal dissection: an experimental study in a swine model (2024 · Esophagus · 被引 6)
• Fecal Calprotectin is a Useful Biomarker for Defining Small Bowel Endoscopic Remission in Crohn’s Disease Without Active Colonic Lesions: A Prospective Multicenter Study from the IBD-Quality Team (2025 · Inflammatory Bowel Diseases · 被引 4)
• Risk of extraintestinal cancer in patients with inflammatory bowel disease: a multicenter retrospective cohort study in Japan (2026 · Journal of Gastroenterology · 被引 2)